Evaluating the Effects of tDCS on Sleep and Cognition in Healthy Older Adults

May 6, 2026 updated by: Northumbria University

Evaluating the Effects of tDCS on Sleep and Cognition in Healthy Older Adults: A Randomised Controlled Trial Using a Nap Design

The goal of this interventional study is to learn if transcranial direct current stimulation (tDCS), a gentle, cost-effective and non-invasive brain stimulation technique can improve sleep brain activity during an afternoon nap. Since these sleep brain patterns are linked to better memory, attention, and thinking skills, this study aims to find out if improving sleep in a nap can also enhance these cognitive skills in healthy older adults (aged 60+).

The main questions it aims to answer are:

  • Can a short (20-minute) tDCS session before a nap improve sleep patterns during the nap?
  • Since these sleep patterns are linked to memory and attention, can tDCS also improve thinking skills after the nap?
  • Are two tDCS session more effective than one for improving nap sleep and thinking skills?

Participants will:

• Be required to come to the university for testing over four days.

During each session they will:

  • Complete computer based-tasks to assess memory and thinking.
  • Receive a 20-minute session of either real (active) or fake (placebo) tDCS.
  • Take a short, monitored nap while researchers measure sleep activity (using polysomnography - a gold-standard, non-invasive sleep monitoring tool).
  • Complete an easy-to-use sleep test at home on the nights after the naps.

    • Wear a lightweight watch (called an Actiwatch) throughout the study period to track sleep and movement.
    • Complete daily sleep diaries.

By taking part, participants will help researchers understand whether tDCS can improve sleep during naps and, in turn, support memory and thinking skills. This research could lead to better treatments for sleep problems, help protect brain health, and reduce the risk of dementia as people age. The brain stimulation in this study may also help improve their sleep and cognition.

Study Overview

Detailed Description

Sleep is vital for maintaining physical and cognitive health across the lifespan. However, normal age-related changes to sleep can impair memory, learning, and waste clearance in the brain, contributing to the risk of cognitive decline and dementia.

Transcranial direct current stimulation (tDCS), a non-invasive technique that modulates brain activity, shows promise for enhancing both sleep and cognition. However, existing studies have significant methodological limitations. Notably, very few have investigated 'offline' tDCS -where stimulation is applied before sleep- to assess objective sleep changes using polysomnography (PSG). Instead, most research has relied on subjective measures, consistently finding that offline tDCS enhances perceived sleep quality, especially with repeated stimulation sessions. Importantly, offline tDCS may be more feasible for use outside laboratory settings compared to 'online' approaches, where stimulation is applied during sleep, making it a more scalable intervention.

Furthermore, delivering tDCS before a daytime nap, rather than nocturnal sleep, offers additional advantages by reducing participant burden, particularly in older adults. Studies applying tDCS during a nap in older adults have shown improvements in objective sleep microstructure and declarative memory. By contrast, studies applying tDCS during nocturnal sleep have reported inconsistent results. Despite its potential benefits, no studies have explored the effects of an offline, nap-based tDCS approach on objective sleep outcomes.

Additionally, few studies have examined whether repeated sessions of offline tDCS might amplify its effects on objective PSG-measured sleep. While repeated sessions have been shown to positively influence subjective sleep outcomes, it remains unclear whether the same benefits apply to objective sleep metrics. This study will address this gap by investigating whether two sessions of offline tDCS, compared to one, are necessary to improve objective sleep outcomes.

In summary, this study aims to determine whether offline tDCS applied prior to a nap can enhance objective sleep during a daytime nap and improve post-nap cognitive performance in older adults. If effective, this low-burden, non-invasive intervention could serve as a practical tool for promoting healthy aging and reducing dementia risk.

The primary objectives of this randomised, placebo-controlled crossover trial are:

To evaluate the impact of offline tDCS on objective sleep microstructure and architecture during naps.

To assess the effects of tDCS on post-nap cognitive performance. To examine the cumulative effect of two tDCS sessions upon objective sleep and cognition, compared to one.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Newcastle upon Tyne, United Kingdom, NE1 8ST
        • Northumbria University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged 60+ years
  • Speak fluent English
  • Be cognitively healthy
  • A self-reported good sleeper, with a regular sleep pattern

Exclusion Criteria:

  • The presence of any major physical or psychiatric illness or comorbidities
  • Self-reported neurodegenerative dementia or other neurological disorders
  • Self-reported relevant sleep disorders or disturbances
  • Those with irregular sleep schedules (i.e. night shift workers)
  • A PSQI score above 5 (as this is associated with significant sleep disturbance)
  • Relevant skin allergies
  • Taking medication that affects the central nervous system or sleep, or consume caffeine, alcohol or cigarettes excessively
  • Metallic or electronic implants

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active Transcranial Direct Current Stimulation (tDCS)
Transcranial direct current stimulation. Participants will experience a 20-minute session of active tDCS (1.2 mA) on two consecutive days.
Active transcranial direct current stimulation (tDCS). Participants will experience a 20-minute session of active tDCS (1.2 mA) on two consecutive days.
Other Names:
  • tDCS
Placebo Comparator: Placebo Transcranial Direct Current Stimulation (tDCS)
Transcranial direct current stimulation. Participants will experience a 20-minute session of placebo tDCS on two consecutive days.
Placebo Transcranial direct current stimulation (tDCS): Participants will experience a 20-minute session of placebo tDCS on two consecutive days.
Other Names:
  • sham tDCS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep spindle density
Time Frame: During nap immediately after tDCS application
PSG-measured slow (11.99 - 12.99Hz) and fast (13 - 14.99Hz) sleep spindle density
During nap immediately after tDCS application
Sleep spindle amplitude
Time Frame: During nap immediately after tDCS application
PSG-measured slow (11.99 - 12.99Hz) and fast (13 - 14.99Hz) sleep spindle amplitude
During nap immediately after tDCS application
Slow wave sleep amplitude
Time Frame: During nap immediately after tDCS application
PSG-measured SWS amplitude (peak-to-peak, μV)
During nap immediately after tDCS application
Slow wave sleep density
Time Frame: During nap immediately after tDCS application
PSG-measured slow wave sleep density (number of slow waves divided by the minutes of sleep)
During nap immediately after tDCS application
Verbal declarative memory
Time Frame: Baseline (before tDCS/nap) and 15 minutes after the nap
Change in Verbal Paired Associates Word Learning Task performance will be measured by % correct recall at baseline (before the tDCS intervention and nap) compared to % correct recall 15 minutes after the nap has taken place.
Baseline (before tDCS/nap) and 15 minutes after the nap
Attentional Network Task (ANT)
Time Frame: Baseline (before tDCS/nap) and 15 minutes after the nap
Change in Attentional Network Task performance will be measured by Reaction Time (RT) (Milliseconds (ms) at baseline (before the tDCS intervention and nap) compared to RT (ms) 15 minutes after the nap has taken place.
Baseline (before tDCS/nap) and 15 minutes after the nap
Attentional Network Task (ANT)
Time Frame: Baseline (before tDCS/nap) and 15 minutes after the nap
Change in Attentional Network Task performance will be measured by Accuracy (%) at baseline (before the tDCS intervention and nap) compared to Accuracy (%) 15 minutes after the nap has taken place.
Baseline (before tDCS/nap) and 15 minutes after the nap

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visuo-spatial declarative picture memory
Time Frame: Baseline (before tDCS/nap) and 15 minutes after the nap
Change in Picture Memory performance will be measured by Accuracy (% Correct) at baseline (before the tDCS intervention and nap) compared to Accuracy (% Correct) 15 minutes after the nap has taken place.
Baseline (before tDCS/nap) and 15 minutes after the nap
Visuo-spatial declarative location memory
Time Frame: Baseline (before tDCS/nap) and 15 minutes after the nap
Change in Location Memory performance will be measured by Accuracy (% Correct) at baseline (before the tDCS intervention and nap) compared to Accuracy (% Correct) 15 minutes after the nap has taken place
Baseline (before tDCS/nap) and 15 minutes after the nap

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rosie H Musgrave, BA Hons, RPSGT, Northumbria University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Actual)

May 6, 2026

Study Completion (Actual)

May 6, 2026

Study Registration Dates

First Submitted

March 13, 2025

First Submitted That Met QC Criteria

April 14, 2025

First Posted (Actual)

April 22, 2025

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Clinical Trials on Active Transcranial Direct Current Stimulation (tDCS)

Subscribe